Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation - TRICAV-I Trial

NCT06137807 is registered in ClinicalTrials.gov with P+F Products + Features USA Inc. as lead sponsor.

NCT NCT06137807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06137807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation - TRICAV-I Trial
Lead sponsor
P+F Products + Features USA Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 23, 2024
Completion date
September 30, 2029
Enrollment
50 (estimated)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

tricuspid regurgitation, tricuspid valve disease